Nektar Therapeutics
看多

Nektar Pharma - possible short squeeze

157
This is a speculative one as counter trend.

Huge volume stepped in around $16 & $20

reuters data on November 28th shows short interest of 18% of the float, and 11 days to cover. The stock hi fresh highs since august and could pressure those short, extending the potential upside

stop below 20 and target 30.




免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。